Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 2,209 | 270 | 1,919 |
| Samples | 453 | 86 | 362 |
| Peptides | 418 | 77 | 353 |
Function
LDLR · Low density lipoprotein receptor
The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022].
Isoforms & Proteins
7 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 324 amino-acid changes on canonical ENST00000558518 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in LDLR · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in LDLR – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Chronic Myelogenous Leukemia | 6/25 24% | 0/0 0% |
| T-Lymphoblastic Leukemia | 6/40 15% | 0/0 0% |
| Endometrial Carcinoma | 10/42 24% | 23/612 4% |
| Rhabdomyosarcoma | 6/33 18% | 3/171 2% |
| Melanoma | 9/210 4% | 54/1899 3% |
| Colorectal Carcinoma | 12/143 8% | 67/3239 2% |
| Glioblastoma | 2/98 2% | 0/0 0% |
| Oral Cavity Carcinoma | 1/54 2% | 0/0 0% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 2/133 2% |
| Hodgkins Lymphoma | 0/16 0% | 2/122 2% |
| Other Solid Cancers | 2/94 2% | 21/1515 1% |
| Gastric Carcinoma | 1/74 1% | 26/1809 1% |
| Non-Small Cell Lung Carcinoma | 6/304 2% | 14/1390 1% |
| Head and Neck Carcinoma | 4/85 5% | 13/1574 1% |
| Ewings Sarcoma | 0/63 0% | 3/262 1% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 8/810 1% |
| Mesothelioma | 1/62 2% | 1/165 1% |
| Cervical Carcinoma | 0/35 0% | 4/422 1% |
| Non-Cancerous | 1/104 1% | 7/830 1% |
| Ovarian Carcinoma | 0/109 0% | 9/998 1% |
| Bladder Carcinoma | 0/58 0% | 8/956 1% |
| Other Sarcomas | 1/69 1% | 4/699 1% |
| Glioma | 0/52 0% | 14/2127 1% |
| Plasma Cell Myeloma | 2/44 5% | 0/305 0% |
| Breast Carcinoma | 3/144 2% | 16/3264 0% |
| Neuroendocrine Tumour | 1/154 1% | 3/577 1% |
| Hepatocellular Carcinoma | 0/46 0% | 12/2210 1% |
| Germ Cell Tumour | 0/25 0% | 1/169 1% |
| Esophageal Carcinoma | 2/23 9% | 2/769 0% |
| Esophageal Squamous Cell Carcinoma | 1/51 2% | 12/2550 0% |
Mutation Distribution
Where LDLR is mutated · all tissues, split by cell line vs tissue
How many mutations in LDLR were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 2,209 mutations in LDLR
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|